3Uber to invest up to $1.25 billion in Rivian as part of robotaxi deal The Cheap InvestorMarch 19, 2026
The logo of Teva Pharmaceutical Industries is seen during a The logo of Teva Pharmaceutical Industries is seen in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen/File photo Post navigation Previous: Huntington’s treatment helps Teva beat profit estimates as CEO eyes newer drug opportunities